Capstan Medical has recently secured $110 million in funding to develop its robotic platform for treating cardiac disease through less invasive heart valve implants. This funding represents one of the largest medtech financing rounds within the robotics sector this year. Capstan's
FemPulse has recently achieved a significant milestone by obtaining an investigational device exemption (IDE) from the US Food and Drug Administration (FDA). This approval allows the company to conduct a pivotal clinical trial for its neuromodulation system designed to treat overactive bladder
The recent proposal by the FDA to ban the use of electric shock devices has sparked a significant debate among autism advocates and the public. This issue is especially pronounced at the Judge Rotenberg Educational Center near Boston, where such devices have been used on students. The prolonged
The launch of GE HealthCare's Venue Sprint marks a significant leap in the world of portable ultrasound technology. For years, GE HealthCare has been at the forefront of digital health solutions and medical advancements, and the Venue Sprint stands as a testament to their commitment to
Route 92 Medical, a leader in neurovascular intervention, has successfully secured an additional $50 million, extending its Series F financing round to a total of $82 million. This significant capital injection aims to accelerate the company’s global commercialization of innovative medical devices d
The medical device landscape for treating acute ischemic stroke is on the cusp of a major transformation with the recent conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for Anaconda Biomed's ANA Funnel Catheter. This key milestone
